symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
VNRX,0.836,1.711717,177518,65322030,0,0.58-2.74,0.175,VolitionRx Limited,USD,0000093314,US9286611077,928661107,American Stock Exchange,AMEX,Diagnostics & Research,https://www.volition.com,"VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.",Mr. Cameron  Reynolds MBA,Healthcare,US,111,646 650 1351,13215 Bee Cave Parkway,Austin,TX,78738,0.66,1.98,https://financialmodelingprep.com/image-stock/VNRX.png,2012-03-02,False,False,True,False,False
